These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2177733)

  • 1. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. II. Models of mu- and delta-receptor-bound structures for analogues containing Phe4.
    Nikiforovich GV; Golbraikh AA; Shenderovich MD; Balodis J
    Int J Pept Protein Res; 1990 Sep; 36(3):209-18. PubMed ID: 2177733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational features responsible for binding of cyclic analogues of enkephalin to opioid receptors. I. Low-energy peptide backbone conformers of analogues containing Phe4.
    Nikiforovich GV; Balodis J; Shenderovich MD; Golbraikh AA
    Int J Pept Protein Res; 1990 Jul; 36(1):67-78. PubMed ID: 2169468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for the delta-receptor-bound conformation of enkephalin.
    Nikiforovich GV; Balodis J
    FEBS Lett; 1988 Jan; 227(2):127-30. PubMed ID: 2828117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposal for the molecular basis of mu and delta opiate receptor differentiation based on modeling of two types of cyclic enkephalins and a narcotic alkaloid.
    Michel A; Villeneuve G; DiMaio J
    J Comput Aided Mol Des; 1991 Dec; 5(6):553-69. PubMed ID: 1667926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
    Shenderovich MD; Nikiforovich GV; Golbraikh AA
    Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
    Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
    Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
    J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of steric interactions in the delta opioid receptor selectivity of [D-Pen2, D-Pen5]enkephalin.
    Mosberg HI; Haaseth RC; Ramalingam K; Mansour A; Akil H; Woodard RW
    Int J Pept Protein Res; 1988 Jul; 32(1):1-8. PubMed ID: 2851561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.
    Toth G; Russell KC; Landis G; Kramer TH; Fang L; Knapp R; Davis P; Burks TF; Yamamura HI; Hruby VJ
    J Med Chem; 1992 Jun; 35(13):2384-91. PubMed ID: 1320122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
    Hruby VJ; Toth G; Gehrig CA; Kao LF; Knapp R; Lui GK; Yamamura HI; Kramer TH; Davis P; Burks TF
    J Med Chem; 1991 Jun; 34(6):1823-30. PubMed ID: 1648137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptide.
    Heyl DL; Omnaas JR; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
    Int J Pept Protein Res; 1991 Mar; 37(3):224-9. PubMed ID: 1651290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions.
    Chandrakumar NS; Stapelfeld A; Beardsley PM; Lopez OT; Drury B; Anthony E; Savage MA; Williamson LN; Reichman M
    J Med Chem; 1992 Aug; 35(16):2928-38. PubMed ID: 1323677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta opioid receptor selectivity induced by conformational constraints in linear enkephalin-related peptides: 1H 400-MHz NMR study and theoretical calculations.
    Belleney J; Gacel G; Fournié-Zaluski MC; Maigret B; Roques BP
    Biochemistry; 1989 Sep; 28(18):7392-400. PubMed ID: 2554969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.
    Haaseth RC; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
    Int J Pept Protein Res; 1990 Aug; 36(2):139-46. PubMed ID: 2177042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational analysis of beta-methyl-para-nitrophenylalanine stereoisomers of cyclo[D-Pen2, D-Pen5]enkephalin by NMR spectroscopy and conformational energy calculations.
    Shenderovich MD; Kövér KE; Nikiforovich GV; Jiao D; Hruby VJ
    Biopolymers; 1996 Feb; 38(2):141-56. PubMed ID: 8589249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of NMR and fluorescence spectroscopy as well as theoretical conformational analysis in conformation-activity studies of cyclic enkephalin analogues.
    Malicka J; Czaplewski C; Groth M; Wiczk W; Oldziej S; Lankiewicz L; Ciarkowski J; Liwo A
    Curr Top Med Chem; 2004; 4(1):123-33. PubMed ID: 14754380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding to opioid receptors of enkephalin derivatives taking alpha-helical conformation and its dimer.
    Sasaki-Yagi Y; Kimura S; Imanishi Y
    Int J Pept Protein Res; 1991 Oct; 38(4):378-84. PubMed ID: 1665842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.
    Brandt W; Stoldt M; Schinke H
    J Comput Aided Mol Des; 1996 Jun; 10(3):201-12. PubMed ID: 8808737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.